arrow
C

Chiara Casadei

university of bologna
H指数:23
被引数:1,464

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic impact of variants of uncertain significance (VUS) in BRCA genes and homologous recombination repair (HRR) genes in prostate cancer: a real-world multicenter study

BRCA基因和同源重组修复(HRR)基因中意义不明的变异(VUS)对前列腺癌预后的影响:一项真实世界多中心研究

2026-08-040
OA
Biomimetic organo-specific scaffolds reveal lineage-specific adaptations of breast cancer cells in bone metastasis
2026-07-230
PRE
Exploring the promoter regions of cancer predisposition genes in patients with triple-negative breast cancer reveals the presence of rare germline variants

探索三阴性乳腺癌患者中癌症易感基因的启动子区域,发现存在罕见的胚系变异。

2025-05-080
OA
Olaparib as a rescue treatment in platinum-refractory germ-cell tumors: the IGG-02 phase II trial

奥拉帕利作为铂类耐药性生殖细胞肿瘤的挽救治疗:IGG-02期II临床试验

2025-05-010
PRE
Hormonal Therapy In Endometriosis And Breast Cancer Risk Propensity Score-Matched Real-World Analysis

子宫内膜异位症中的激素疗法与乳腺癌风险倾向评分匹配的真实世界分析

2025-02-010
PRE
Detection of circulating tumor DNA and chromosome 3p25.3 gain in relapsed/refractory germ cell tumors and impact of salvage high-dose chemotherapy: Results from the Italian Germ Cell Cancer Group 04 study

循环肿瘤DNA和3p25.3染色体增益在复发/难治性生殖细胞瘤中的检测及挽救性大剂量化疗的影响:意大利生殖细胞癌研究组04研究的结果

2024-09-010
PRE
Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients
2024-08-290
OAAI
Inherited Mutations in DNA Damage Repair Genes in Italian Men with Metastatic Prostate Cancer: Results from the Meet-URO 10 Study
2024-03-014
OAAI
Dynamics of plasma tumour DNA and copy number alterations in advanced metastatic castration-resistant prostate cancer (mCRPC) patients treated with cabazitaxel: A prospective biomarker trial
2023-10-010
OA
Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study
2023-07-013
OAAI
Clinical impact of whole-body magnetic resonance imaging on subsequent management in luminal/HER2-negative breast cancer patients
2023-03-010
PRE